Nuvectis Pharma Inc. (NVCT)

AI Score

Unlock

8.91

0.21 (2.41%)

At close: Apr 17, 2025, 3:59 PM

9.18

2.99%

After-hours: Apr 17, 2025, 04:49 PM EDT

Nuvectis Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Net Income	-6.25M	-4.15M	-4.43M	-4.17M	-6.62M	-5.88M	-5.71M	-4.05M	-6.7M	-5.88M	-3.57M	-2.94M	-2.26M	-4.67M	-5.94M	-23K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	1.14M	-2.58M	1.26M	1.3M	1.22M	1.13M	950K	1.4M	482K	559K	510K	156K	185K	136K	1.57M	n/a
Other Working Capital	2.4M	922K	59K	-471K	1.53M	1.5M	675K	-2.13M	2.7M	-560	516K	-831K	-470K	106K	356K	n/a
Other Non-Cash Items	n/a	3M	1.18M	2.31M	1.2M	1.13M	950K	1.4M	482K	1.51K	510K	156K	185K	136K	1.57M	23K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	2.64M	1.34M	146K	-1.48M	1.55M	1.5M	675K	-2.13M	2.7M	894K	516K	-289K	1.01M	106K	356K	23K
Operating Cash Flow	-2.46M	-2.4M	-3.02M	-4.36M	-3.85M	-3.24M	-4.08M	-4.78M	-3.52M	-4.42M	-2.54M	-3.08M	-1.07M	-4.43M	-4.01M	n/a
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-124K	-50K	-55K	-153K	16K	-423K	9.95M	252K	-131K	-1.39M	-578K	-1.97M	n/a	n/a	11.22M	n/a
Financial Cash Flow	3.83M	1.46M	1.67M	4.7M	917K	703K	13.21M	252K	-131K	14.49M	-578K	14.03M	n/a	4.02M	11.22M	n/a
Net Cash Flow	1.36M	-947K	-1.35M	338K	-2.93M	-2.54M	9.13M	-4.53M	-3.65M	10.07M	-3.12M	10.95M	-1.07M	-405K	7.21M	n/a
Free Cash Flow	-2.46M	-2.4M	-3.02M	-4.36M	-3.85M	-3.24M	-4.08M	-4.78M	-3.52M	-4.42M	-2.54M	-3.08M	-1.07M	-4.43M	-4.01M	n/a